hnical Validation and Refinement of the MARA Rating (The Moody's of Pharma) Model for Reimbursement Feasibility Prediction

• Forschungsstelle: INNOSUISSE
• Projektnummer: 134.437 INNO-LS
• Projekttitel Englisch: hnical Validation and Refinement of the MARA Rating (The Moody's of Pharma) Model for Reimbursement Feasibility Prediction

Schlüsselwörter (Englisch)

Life sciences, Pharmaceuticals

Abstract (Englisch)

MARA Rating is developing the first structured, evidence-based model to assess reimbursement feasibility early in drug development. This project will refine the model?s conceptual foundations by identifying key predictors and methodological improvements needed for future statistical validation.